FDA Law Blog: Biosimilars
MARCH 27, 2023
Such codes need to be placed on device labels and packages to allow devices to be easily identified and tracked throughout their lifecycle, except where the rule provided for an exception or alternative. Once the device is required to bear a UDI, any NHRIC and NDC codes will no longer be permitted on the device label or device packaging.
Olympian Clinical Research
OCTOBER 13, 2022
Be sure to follow the instructions on the package and only use the medication as directed. You can find aloe vera gel at most pharmacies or supermarkets. Some of the ways you may do this are by: Use Anti-Itch Medication. Over-the-counter antihistamines may relieve the itchiness and swelling associated with hives.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 13, 2021
These statements concern, and these risks and uncertainties include, among others, MindMed’s and its collaborators’ ability to continue to conduct research and clinical programs, MindMed’s ability to manage its supply chain, product sales of products marketed by MindMed and/or its collaborators (collectively, ” Products”), (..)
The Pharma Data
NOVEMBER 5, 2020
Food and Drug Administration (“FDA”) will grant an Emergency Use Authorization (“EUA”) for REGN-COV2 and, if an EUA is granted, the scope and terms of such EUA and how long such EUA would remain in effect for REGN-COV2; the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron’s product candidates (such (..)
The Pharma Data
OCTOBER 30, 2020
Food and Drug Administration (“FDA”) with respect to a potential Emergency Use Authorization (“EUA”) for REGN-COV2, and possible regulatory approval of REGN-COV2; whether the FDA will grant an EUA for REGN-COV2 and, if an EUA is granted, the scope and terms of such EUA and how long such EUA would remain in effect for REGN-COV2; (..)
Agency IQ
AUGUST 4, 2023
a wholesaler or pharmacy) would be able to see a valid chain of custody for a product. They may seek “exceptions… to the requirements relating to product identifiers if a product is packaged in a container too small or otherwise unable to accommodate a label.” The system is intended to increase transparency and safety.
The Pharma Data
DECEMBER 17, 2020
Food and Drug Administration (the “FDA”) for casirivimab and imdevimab will remain in effect and whether the EUA is revoked by the FDA based on its determination that the underlying health emergency no longer exists or warrants such authorization or other reasons; the likelihood, timing, and scope of possible regulatory approval and commercial (..)
Expert insights. Personalized for you.
45 
Let's personalize your content